Bigbear Pharmaceutical·Medication Guide

• Pemigatinib Detailed Instructions: Indications, Dosage and Administration, Side Effects, Precautions

  Pemigatinib has proven therapeutic activity in patients with previously treated locally advanced/metastatic cholangiocarcinoma with FGFR2 fusions/rear···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 124

• Pemigatinib Dosage and Administration: Medication Guidelines, Dosage Adjustment, Use in Special Popu

  Properly understanding the timing of pemigatinib administration, adjusting the appropriate dosage, and its interactions with food are crucial for impr···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 112

• Side Effects and Common Adverse Reactions of Pemigatinib

  While pemigatinib exerts its therapeutic effect, it may also cause different types and degrees of adverse reactions due to individual differences in p···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 120

• Detailed Information about Pemigatinib

  The price of Pemigatinib is subject to fluctuations due to factors such as drug specifications, region, medical insurance policies, and purchasing cha···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 102

• Pemigatinib Cost Per Month: What Cholangiocarcinoma Patients Pay in 2026

  Pemigatinib is a targeted therapy drug for specific cholangiocarcinoma patients. Its price is affected by factors such as dosage, region, and medical ···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 104

• Pemazyre (pemigatinib) has been approved in the European Union

  Incyte recently announced that the European Commission (EC) has approved Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) ···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 118

• Pemigatinib (Pemazyre) Shows Promise in Telemedicine Trial for Pancreatic Cancer

  In April 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Pemazyre (pemigatinib) oral tablets, developed by Incyte, f···【Read More】

  Update: 2026-04-09Source: Haiou HealthViews: 107

• Storage Instructions for Palbociclib

  Store palbociclib in its original blister pack at a temperature of 68°F to 77°F (20°C to 25°C).Keep the medication out of the reach of children.【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 111

• Which Medications May Interact with Palbociclib?

  Inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, ···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 107

• What If an Overdose of Palbociclib Occurs?

  In the event of an accidental overdose of palbociclib, contact your healthcare provider immediately or proceed directly to the nearest hospital emerge···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 111

• What to Do If a Dose Is Missed?

  If you skip a dose of palbociclib or experience vomiting shortly after taking a dose, do not administer an additional dose on the same day. Resume you···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 127

• A New Drug for FGFR1 Myeloid or Lymphoid Cancers! FDA Approves Pemazyre (pemigatinib)

  On August 26, 2022, Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre (pemigatinib) for the treatment of adult p···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 111

• Palbociclib Price Comparison 2026: Brand vs Generic

  The price of palbociclib is significantly affected by drug specifications, regional policies, and purchasing channels. In China, the price per box typ···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 115

• IBRANCE (Palbociclib) Drug Guidelines

  On March 31, 2017, the U.S. Food and Drug Administration (FDA) granted palbociclib (IBRANCE, Pfizer) general approval for the treatment of hormone rec···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 131

• FDA Approves Ibrance for Treatment of Postmenopausal Women with Advanced Breast Cancer

  The U.S. Food and Drug Administration (FDA) has approved Ibrance (palbociclib) for the treatment of advanced (metastatic) breast cancer.Breast cancer ···【Read More】

  Update: 2026-04-08Source: Haiou HealthViews: 133